Jessica Tassan
Stock Analyst at Piper Sandler
(1.15)
# 3,869
Out of 5,127 analysts
80
Total ratings
32.84%
Success rate
-11.32%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALHC Alignment Healthcare | Maintains: Overweight | $20 → $30 | $20.95 | +43.20% | 6 | Jan 6, 2026 | |
| CVS CVS Health | Reiterates: Overweight | $99 → $101 | $80.60 | +25.31% | 6 | Dec 10, 2025 | |
| OSCR Oscar Health | Upgrades: Overweight | $13 → $25 | $16.90 | +47.93% | 7 | Nov 26, 2025 | |
| HNGE Hinge Health | Reiterates: Overweight | $70 → $71 | $49.41 | +43.70% | 2 | Nov 5, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $423 → $417 | $346.85 | +20.22% | 9 | Oct 29, 2025 | |
| PHR Phreesia | Maintains: Overweight | $33 → $34 | $16.90 | +101.18% | 6 | Sep 5, 2025 | |
| EVH Evolent Health | Maintains: Overweight | $16 → $18 | $4.16 | +332.69% | 4 | Aug 28, 2025 | |
| HCAT Health Catalyst | Downgrades: Neutral | $8 → $4 | $2.45 | +63.27% | 12 | Aug 27, 2025 | |
| CTEV Claritev | Maintains: Overweight | $44 → $86 | $31.21 | +175.55% | 3 | Aug 15, 2025 | |
| DOCS Doximity | Maintains: Overweight | $65 → $69 | $43.74 | +57.75% | 4 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $288 → $272 | $277.57 | -2.01% | 4 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $10 → $8 | $5.17 | +54.74% | 3 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $348 → $374 | $283.91 | +31.73% | 4 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $12 | $7.61 | +57.69% | 6 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $66 → $70 | $50.59 | +38.37% | 4 | Aug 2, 2023 |
Alignment Healthcare
Jan 6, 2026
Maintains: Overweight
Price Target: $20 → $30
Current: $20.95
Upside: +43.20%
CVS Health
Dec 10, 2025
Reiterates: Overweight
Price Target: $99 → $101
Current: $80.60
Upside: +25.31%
Oscar Health
Nov 26, 2025
Upgrades: Overweight
Price Target: $13 → $25
Current: $16.90
Upside: +47.93%
Hinge Health
Nov 5, 2025
Reiterates: Overweight
Price Target: $70 → $71
Current: $49.41
Upside: +43.70%
UnitedHealth Group
Oct 29, 2025
Maintains: Overweight
Price Target: $423 → $417
Current: $346.85
Upside: +20.22%
Phreesia
Sep 5, 2025
Maintains: Overweight
Price Target: $33 → $34
Current: $16.90
Upside: +101.18%
Evolent Health
Aug 28, 2025
Maintains: Overweight
Price Target: $16 → $18
Current: $4.16
Upside: +332.69%
Health Catalyst
Aug 27, 2025
Downgrades: Neutral
Price Target: $8 → $4
Current: $2.45
Upside: +63.27%
Claritev
Aug 15, 2025
Maintains: Overweight
Price Target: $44 → $86
Current: $31.21
Upside: +175.55%
Doximity
Aug 11, 2025
Maintains: Overweight
Price Target: $65 → $69
Current: $43.74
Upside: +57.75%
Jul 31, 2025
Maintains: Neutral
Price Target: $288 → $272
Current: $277.57
Upside: -2.01%
May 23, 2025
Reiterates: Neutral
Price Target: $10 → $8
Current: $5.17
Upside: +54.74%
May 5, 2025
Maintains: Overweight
Price Target: $348 → $374
Current: $283.91
Upside: +31.73%
Feb 27, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $7.61
Upside: +57.69%
Aug 2, 2023
Downgrades: Neutral
Price Target: $66 → $70
Current: $50.59
Upside: +38.37%